Home

Mirikizumab

Tender information

TED EU

Tallinn, Estonia

Type
29
Procedure
open
Ref. number
260400-2025
Estimated value
1,655,002 EUR
CPV
33600000

Ravimite ostmine vastavalt RHAD lisas I Tehniline kirjeldus-pakkumuse vorm kirjeldatule.

Show all tender information

Documents

Show all important dates